Roche’s Xofluza Receives the EC’s Approval for the Treatment of Influenza
Shots: The EC has approved Xofluza (baloxavir marboxil) for uncomplicated influenza in patients aged≥12yrs. Additionally, the EC has approved Xofluza for post-exposure prophylaxis of influenza […]